You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
飛鶴(06186.HK)2021年財報:研發投入大增60% 母乳研究國際領先
格隆匯 03-29 08:13

3月28日晚間,中國飛鶴(股票代碼:06186.HK)(下稱“飛鶴”)發佈2021年全年業績,實現營收人民幣227.8億元,同比增長22.5%。今日上午業績發佈會透露去年投入研發費用4.3億元,同比增長60.5%。

持續的研發創新是驅動飛鶴穩健高質量發展的核心動力。從成果來看,2009年至今,共承擔25項國家及省級重要科研項目,僅2021年在國內外權威期刊就發表了39篇,開展2項科研臨牀試驗,獲得授權專利105項,參與12項國家、行業及團隊標準制定。

值得一提的是,在母乳研究方面,飛鶴創下多個國際國內“首次”,如發表了國內首個母乳低聚糖動態變化趨勢的系統性綜述、首次將中國母乳代謝型與嬰幼兒生長髮育關聯、首次揭示顯著不同的蛋白質會影響嬰兒的免疫反應和能量代謝等。

從產業轉化成果來看,僅去年一年,飛鶴就推出了特醫食品蓓舒消、有機兒童奶粉臻稚、成人奶粉愛本、羊奶粉小羊妙可、佳瑞妙可、加愛六款新品。併成功在臻稚有機產品中添加了全球首款有機專利OPO,使SN-2棕櫚酸的含量達到67%,開啟有機配方新時代。長期來看,飛鶴始終堅持戰略性全產業鏈研發投入,不斷為其穩健發展增強競爭力,拓寬護城河。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account